NCT07891182
VGFTe-(HD)-OD-2566: Adjunctive Aflibercept Ahmed Glaucoma Valve (AAA) Study
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Intraocular pressure
Timeframe: Postoperative day 1, week 1, month 1, month 2, and month 3
Secondary (4)
Surgical failure
Medication Burden
Hypertensive phase
Treatment adverse events and serious treatment adverse events
Arms and interventions
Ahmed Tube Surgery with Aflibercept Intravitreal Injection GroupExperimental
Participants will undergo standard of care Ahmed tube surgery and will receive one 8 mg injection of intravitreal aflibercept at three timepoints in the study: at the conclusion of surgery, Postoperative Month 1, Postoperative Month 2. Total duration of participation in this arm is 6 months
Ahmed Tube Surgery without Perioperative Aflibercept (Control Group)Active comparator
Participants will undergo standard of care Ahmed tube surgery without any injections of intravitreal aflibercept. Total duration of participation in this arm is 6 months.
Drugs: Aflibercept Injection
Procedures: Ahmed Tube Surgery
Sites
1 site in 1 country
- Bascom Palmer Eye InstituteMiami, Florida, United States